|
1
|
Burningham Z, Hashibe M, Spector L and
Schiffman JD: The epidemiology of sarcoma. Clin Sarcoma Res.
2:142012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fuchs HE and Jemal
AM: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
WHO Classification of Tumours Editorial
Board, . Soft tissue and bone tumors: WHO Classification of Tumors
Series. 5th edition. Vol 3. International Agency for Research on
Cancer; Lyon: 2020
|
|
4
|
Sung JJ, Kyeong SK, Kyo WL, Jae BP,
Yoon-La C, Jeong IY, Su JL, Dong IC and Sung JK: Distribution and
survival of primary sarcoma in Korea: A single center analysis of
2017 cases. Korean J Clin Oncol. 14:30–36. 2018. View Article : Google Scholar
|
|
5
|
Kim HS, Nam CM, Jang SY, Choi SK, Han M,
Kim S, Moneta MV, Lee SY, Cho JM, Novick D and Rha SY:
Characteristics and treatment patterns of patients with advanced
soft tissue sarcoma in Korea. Cancer Res Treat. 51:1380–1391. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wood ME, Vogel V, Ng A, Foxhall L, Goodwin
P and Travis LB: Second malignant neoplasms: Assessment and
strategies for risk reduction. J Clin Oncol. 30:3734–3745. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang MJ, Won YJ, Lee JJ, Jung KW, Kim HJ,
Kong HJ, Im JS and Seo HG; Community of Population-Based Regional
Cancer Registries, : Community of population-based regional cancer
registries: Cancer statistics in Korea: Incidence, mortality,
survival, and prevalence in 2019. Cancer Res Treat. 54:330–344.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vogt A, Schmid S, Heinimann K, Frick H,
Herrmann C, Cerny T and Omlin A: Multiple primary tumors:
Challenges and approaches, a review. ESMO Open. 2:e0001722017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Choi DK, Helenowski I and Hijiya N:
Secondary malignancies in pediatric cancer survivors: Perspectives
and review of the literature. Int J Cancer. 135:1764–1773. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bright CJ, Reulen RC, Winter DL, Stark DP,
McCabe MG, Edgar AB, Frobisher C and Hawkins MM: Risk of subsequent
primary neoplasms in survivors of adolescent and young adult cancer
(Teenage and Young Adult Cancer Survivor Study): A
population-based, cohort study. Lancet Oncol. 20:531–545. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chao C, Bhatia S, Xu L, Cannavale KL, Wong
FL, Huang PS, Cooper R and Armenian SH: Incidence, risk factors,
and mortality associated with second malignant neoplasms among
survivors of adolescent and young adult cancer. JAMA Netw Open.
2:e1955362019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Demoor-Goldschmidt C and de Vathaire F:
Review of risk factors of secondary cancers among cancer survivors.
Br J Radiol. 92:201803902019.PubMed/NCBI
|
|
13
|
Mertens AC, Liu Q, Neglia JP, Wasilewski
K, Leisenring W, Armstrong GT, Robison LL and Yasui Y:
Cause-specific late mortality among 5-year survivors of childhood
cancer: The childhood cancer survivor study. J Natl Cancer Inst.
100:1368–1379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Friedman DL, Whitton J, Leisenring W,
Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison
LL and Neglia JP: Subsequent neoplasms in 5-year survivors of
childhood cancer: The childhood cancer survivor study. J Natl
Cancer Inst. 102:1083–1095. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
The Lancet Haematology, . Secondary
haematological malignancies. Lancet Haematol. 10:e792023.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sill H, Olipitz W, Zebisch A, Schulz E and
Wölfler A: Therapy-related myeloid neoplasms: Pathobiology and
clinical characteristics. Br J Pharmacol. 162:792–805. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Strauss SJ, Frezza AM, Abecassis N, Bajpai
J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, et
al: Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical
Practice Guideline for diagnosis, treatment and follow-up. Ann
Oncol. 32:1520–1536. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
National Comprehensive Cancer Network
(NCCN), . Soft Tissue Sarcoma (Version 2.2023). NCCN; Plymouth
Meeting, PA: 2023, https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdfMay
12–2023
|
|
19
|
National Comprehensive Cancer Network
(NCCN), . Bone Cancer (Version 3.2023). NCCN; Plymouth Meeting, PA:
2023, https://www.nccn.org/professionals/physician_gls/pdf/bone.pdfMay
12–2023
|
|
20
|
Bhatia S, Krailo MD, Chen Z, Burden L,
Askin FB, Dickman PS, Grier HE, Link MP, Meyers PA, Perlman EJ, et
al: Therapy-related myelodysplasia and acute myeloid leukemia after
Ewing sarcoma and primitive neuroectodermal tumor of bone: A report
from the Children's Oncology Group. Blood. 109:46–51. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hong KT, Choi JY, Hong CR, Kang HJ, Park
KD and Shin HY: Therapy-related acute myeloid leukemia after the
treatment of primary solid cancer in children: A single-center
experience. J Pediatr Hematol Oncol. 40:e23–e28. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sanford NN, Martin AM, Brunner AM, Cote
GM, Choy E, DeLaney TF, Aizer AA and Chen YL: Secondary acute
leukemia in sarcoma patients: A population-based study. Int J
Radiat Oncol Biol Phys. 100:687–694. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kube SJ, Blattmann C, Bielack SS, Kager L,
Kaatsch P, Kühne T, Sorg B, Kevric M, Jabar S, Hallmen E, et al:
Secondary malignant neoplasms after bone and soft tissue sarcomas
in children, adolescents, and young adults. Cancer. 128:1787–1800.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nagar SP, Mytelka DS, Candrilli SD,
D'yachkova Y, Lorenzo M, Kasper B, Lopez-Martin JA and Kaye JA:
Treatment patterns and survival among adult patients with advanced
soft tissue sarcoma: A retrospective medical record review in the
United Kingdom, Spain, Germany, and France. Sarcoma.
2018:54670572018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeong H, Im HS, Kim W, Lee JS, Song SY,
Song JS, Cho KJ, Chung HW, Lee MH, Kim JE and Ahn JH: Demographics,
changes in treatment patterns, and outcomes of bone and soft tissue
sarcomas in Korea-a sarcoma-specific, institutional registry-based
analysis. Cancer Manag Res. 13:8795–8802. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu YC, Illar GM, Al Amri R, Canady BC,
Rea B, Yatsenko SA and Geyer JT: Therapy-related myeloid neoplasms
with different latencies: A detailed clinicopathologic analysis.
Mod Pathol. 35:625–631. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cancer Genome Atlas Research Network, .
Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A,
Hoadley K, Triche TJ Jr, Laird PW, et al: Genomic and epigenomic
landscapes of adult de novo acute myeloid leukemia. N Engl J Med.
368:2059–2074. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McNerney ME, Godley LA and Le Beau MM:
Therapy-related myeloid neoplasms: When genetics and environment
collide. Nat Rev Cancer. 17:513–527. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ruan J and Han B: Effective treatment of
aplastic anemia secondary to chemoradiotherapy using cyclosporine
A. Chin Med J (Engl). 134:2356–2358. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Italiano A, Mathoulin-Pelissier S, Cesne
AL, Terrier P, Bonvalot S, Collin F, Michels JJ, Blay JY, Coindre
JM and Bui B: Trends in survival for patients with metastatic
soft-tissue sarcoma. Cancer. 117:1049–1054. 2011. View Article : Google Scholar : PubMed/NCBI
|
